All In Biotech

Free tool

FAERS Monitor: Travatan Z

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021994 or its brand name (Travatan Z, Travoprost). Reports on generic versions are filed under their own applications.

Reports

8,671

Serious

3,182

37% of reports

Hospitalization

1,143

Death reported

333

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure1,951
  • drug ineffective545
  • ocular hyperaemia503
  • eye irritation499
  • eye pain352
  • intraocular pressure increased299
  • hypersensitivity269
  • fatigue268
  • glaucoma260
  • headache237
  • dizziness236
  • vision blurred236
  • visual impairment226
  • death208
  • dyspnoea206

Reports by year received

View as table
YearReports
200416
200547
200632
200735
200837
200955
201068
201185
2012114
2013113
2014164
2015361
2016633
2017821
2018792
2019743
20202,608
2021483
2022355
2023291
2024253
2025325
2026240

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,488 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
treatment failureSignal1,95158.556.2107,996
intraocular pressure increasedSignal29958.151.916,337
glaucomaSignal26033.229.47,983
ocular hyperaemiaSignal50326.023.811,952
eye irritationSignal49921.219.59,529
eye painSignal35215.213.74,647
visual impairmentSignal2264.43.9599
vision blurredSignal2364.23.7569
hypersensitivitySignal2693.53.1486
dizziness2361.11.04
drug ineffective5451.00.90
headache2370.90.82
dyspnoea2060.90.83
fatigue2680.80.79
death2080.60.563

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.